schizandrin b has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, LH; Hu, KY; Jia, ZR; Li, SR; Li, XJ; Mao, J; Tian, W; Wang, DW; Yang, Y; Zhang, W | 1 |
| Arumugam, S; Giridharan, VV; Ko, KM; Konishi, T; Krishnamurthy, P; Suzuki, K; Thandavarayan, RA; Watanabe, K | 1 |
| Che, FF; Liu, Y; Xu, CG | 1 |
3 other study(ies) available for schizandrin b and Cardiomyopathies
| Article | Year |
|---|---|
[Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiomyopathies; Cardiotoxicity; Cyclooctanes; Dexrazoxane; Doxorubicin; Heart; Lignans; Myocardium; Polycyclic Compounds; Rats; Rats, Sprague-Dawley | 2014 |
Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiomyopathies; Cyclooctanes; Disease Models, Animal; Doxorubicin; Gene Expression Regulation; Lignans; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Polycyclic Compounds; Tyrosine; Ventricular Function, Left | 2015 |
[Schisandrin B prevents doxorubicin-induced cardiotoxicity in rabbits].
Topics: Animals; Apoptosis; Cardiomyopathies; Cyclooctanes; Doxorubicin; Female; Lignans; Lipid Peroxidation; Male; Natriuretic Peptide, Brain; Polycyclic Compounds; Rabbits; Random Allocation; Reactive Oxygen Species; Schisandraceae; Superoxide Dismutase; Troponin I | 2010 |